The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic may increase the risks and failure rate of delivering a safe, effective vaccine. Il primo teorizzatore del modello moderno di sovranità è sicuramente Jean Bodin(1576), che cercò di cogliere da subito la sintesi di quale fosse la qualità dei poteri che spettano al sovrano. Biography. [7][81][82][83], Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent influenza, but rather are using "next-generation" strategies for precision on COVID‑19 infection mechanisms. [391][392] BBV152 has not published efficacy results as of 7 January. [91][92], These vaccines are examples of non-replicating viral vectors, using an adenovirus shell containing DNA that encodes a SARS‑CoV‑2 protein. [22][11] Afeyan personally owned 19.5% of Moderna and was the largest single shareholder, while his fund, Flagship Pioneering, owned 18%. ", "Investigating a Vaccine Against COVID-19", "A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19", "A Phase III study to investigate a vaccine against COVID-19", "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants", "Vaccine adjuvants: Current state and future trends", "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)", "Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)", "A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia", "A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)", "Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults", "Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)", "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant", "A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults", "A prospective, randomized, adaptive, phase I/II clinical study to evaluate the safety and immunogenicity of Novel Corona Virus −2019-nCov vaccine candidate of M/s Cadila Healthcare Limited by intradermal route in healthy subjects", "Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers", "IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO's COVID-19 DNA vaccine in South Korea", "Study of COVID-19 DNA Vaccine (AG0301-COVID19)", "Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults", "S. Korea's Genexine begins human trial of coronavirus vaccine", "Safety and Immunity of Covid-19 aAPC Vaccine", "Immunity and Safety of Covid-19 Synthetic Minigene Vaccine", "GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine", "A Phase I/II Randomized, Multi-Center, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (IIBR-100) in Adults", "Can old vaccines from science's medicine cabinet ward off coronavirus? They have launched a trial of a new vaccine to tackle the South African variant. [426] The declaration is effective in the United States through 1 October 2024. [11][12][13] As of November 2020[update], the Moderna COVID-19 vaccine candidate, mRNA-1273, had shown preliminary evidence of 94% efficacy in preventing COVID-19 disease in a Phase III trial, with only minor flu-like side effects. Lo scontro tra assolutismo e costituzione mista diede modo alle dottrine sulla sovranità di diffondersi, in una prospettiva divergente rispetto alle teorie costituzionali, tanto che proprio nella costituzione mista si individuò la causa più rilevante del conflitto e della guerra civile. Età moderna. [415][416][418] In April, it was reported that the UK agreed to work with 20 other countries and global organizations including France, Germany and Italy to find a vaccine and to share the results and that UK citizens would not get preferential access to any new COVID‑19 vaccines developed by taxpayer-funded UK universities. [24], In May 2020, board member Dr. Moncef Slaoui resigned from the company to become Chief Scientist for the Trump administration's "Operation Warp Speed", a group designed to accelerate the development of a vaccine for the coronavirus. Vaccines in clinical trials include Johnson & Johnson's Ad26.COV2.S. [19], The urgency to create a vaccine for COVID‑19, led to compressed schedules that shortened the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years. [93] The viral vector-based vaccines against COVID-19 are non-replicating, meaning that they do not make new virus particles, but rather produce only the antigen which elicits a systemic immune response. [35], The Moderna COVID-19 vaccine candidate, mRNA-1273, was shown in a Phase I trial to be immunogenic in a small number of volunteers aged 18–55 years. [26][27][28] Additionally, research at universities is obstructed by physical distancing and closing of laboratories. [31][32] A Phase I–II trial consists of preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, while determining more precise, effective doses. [100], As of January 2021, authorized vaccines of this type are the Chinese CoronaVac[101][102][103] and BBIBP-CorV[104] as well as the Indian Covaxin. [14][17] As of March 2020, there was one (DNA based) MERS vaccine which completed Phase I clinical trials in humans[18] and three others in progress, all being viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) and one MVA-vectored (MVA-MERS-S). ... L’età moderna. [11], In 2018, the company rebranded as "Moderna Inc." with the ticker symbol MRNA, and further increased its portfolio of vaccine development. [11] After Noubar Afeyan and Robert Langer, Bancel is the largest individual shareholder in the company. Esempio di periodizzazione della storia mondiale. Tag: età moderna Josef Hoffmann – Architetto e Designer Austriaco (1870-1956) L’architetto della città di Vienna Josef Franz Maria Hoffmann è stato uno dei maggiori architetti austriaci del tardo Ottocento. [45] Three Chinese vaccine companies and research institutes are supported by the government for financing research, conducting clinical trials, and manufacturing. [20][24], Since early 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. [32][33] The year-end 2019 SEC filings showed that Moderna had accumulated losses of $1.5 billion since inception, with a loss of $514 million in 2019 alone, and had raised $3.2 billion in equity since 2010. [122] There is experimental evidence that the BCG vaccine for tuberculosis has non-specific effects on the immune system, but no evidence that this vaccine is effective against COVID‑19. La vida moderna espainiar irratsaio satiriko eta ironikoa da.Irratsaio hau 2014an sortu zen Cadena SER-en, David Broncano (aurkezlea), Quequé (aurkezlekidea) eta Ignatius (aurkezlekidea) kideekin. Guztira 500 programa baino gehiago egin dituzte. Prior to the COVID‑19 pandemic, work to develop a vaccine against coronavirus diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) established knowledge about the structure and function of coronaviruses; this knowledge enabled accelerated development of various vaccine technologies during early 2020. The relative success of AZD8601 is attributed to the fact that Moderna has been able to inject mRNA direct into the heart muscle without needing a drug delivery system. [46] Great Britain formed a COVID‑19 vaccine task force in April 2020 to stimulate local efforts for accelerated development of a vaccine through collaborations of industry, universities, and government agencies. [435] In mid-2020, estimates from two surveys were that 67% or 80% of people in the U.S. would accept a new vaccination against COVID‑19, with wide disparity by education level, employment status, race, and geography. [398], At the University of Oxford, researchers have as of early February 2021 begun enrolling volunteers in an 820 person trial to evaluate the efficacy of combining two different vaccines, a mix and match approach, as opposed to using two doses of the same vaccine. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away", "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine", "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020", "FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution", "Non-viral COVID-19 vaccine delivery systems", "Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery", "Three decades of messenger RNA vaccine development", "Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine", "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults", United States National Library of Medicine, "A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults", "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19", "COVID-19 vaccine candidate heads to widespread testing in U.S.", "What are viral vector-based vaccines and how could they be used against COVID-19? L'è lónga sirca tri sècoi, da la segónda mità del XV (o prensépe del XVI) a la fì del XVIII (o prima mità del XIX). [39], Stephen Hoge, M.D., is president and a former McKinsey & Company management consultant who joined in 2012; he is the fourth-largest individual shareholder in the company. You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. Latest news on UK trials", "COVAX: Ensuring global equitable access to COVID-19 vaccines", "R&D Blueprint: A coordinated global research roadmap – 2019 novel coronavirus", "Notice of Declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID-19", "Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU", "COVID-19: MEPs want safe vaccines, full transparency and liability for companies", "WHO Director-General's opening remarks at 148th session of the Executive Board", "Bahrain approves Chinese COVID-19 vaccine for use", "UAE says Sinopharm vaccine has 86% efficacy against COVID-19", "China's Sinopharm vaccine offered to elite few in UAE tourist deal", "Ten health issues WHO will tackle this year", "Determinants of COVID-19 vaccine acceptance in the US", "Poll shows 61 percent of Americans likely to take COVID-19 vaccine", "Mike Pence receives Covid-19 vaccine on live TV: 'I didn't feel a thing, "Obama, Clinton and Bush pledge to take Covid vaccine on TV to show its safety", "A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic", Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry, "The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial Works", "Every Covid-19 Vaccine Question You'll Ever Have, Answered", "A New Entry in the Race for a Coronavirus Vaccine: Hope", "Protocol C4591001 PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines)", "STAT's Covid-19 Drugs and Vaccines Tracker", "COVID-19 vaccines: development, evaluation, approval and monitoring", Decentralized Privacy-Preserving Proximity Tracing, Sancaktepe Prof. Dr. Feriha Öz Emergency Hospital, Yeşilköy Prof. Dr. Murat Dilmener Emergency Hospital, NHS Nightingale Hospital Yorkshire and the Humber, Kandakadu Treatment and Rehabilitation Centre, Coalition for Epidemic Preparedness Innovations, International Committee on Taxonomy of Viruses, COVID-19 Response Acceleration Task Force, Great American Economic Revival Industry Groups, Inter-Agency Task Force on Emerging Infectious Diseases, National COVID-19 Coordination Commission, Africa Centres for Disease Control and Prevention, Coronavirus Scientific Advisory Board (Turkey), Korea Disease Control and Prevention Agency, Tests, cases, tests per capita, cases per capita by country, Tests, cases, tests per capita, cases per capita by country subdivision, World map by countries: confirmed per capita, Cedillo v. Secretary of Health and Human Services, https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&oldid=1006002248, Medical responses to the COVID-19 pandemic, Pages with non-numeric formatnum arguments, CS1 Norwegian Bokmål-language sources (nb), Short description is different from Wikidata, Wikipedia indefinitely semi-protected pages, Articles containing potentially dated statements from February 2021, All articles containing potentially dated statements, Interlanguage link template existing link, Articles to be expanded from January 2021, Articles containing potentially dated statements from September 2020, Articles with limited geographic scope from December 2020, Creative Commons Attribution-ShareAlike License, This page was last edited on 10 February 2021, at 14:34. [29] By 2016, Bancel told an audience of JPMorgan Chase investors that the work with Alexion would shortly enter human trials. Le donne nell'Età moderna erano disprezzate degli uomini: la mentalità dominante era quella maschilista (superiorità dell'uomo rispetto alle donne) e misoginia (il disprezzo delle donne). [418], On 4 February 2020, US Secretary of Health and Human Services Alex Azar published a notice of declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID‑19, covering "any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus mutating therefrom", and stating that the declaration precludes "liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct". At the 2018 IPO, documents filed stated that Afeyan owned 19.5% of the company, while Flagship owned 18%, thus giving Afeyan control over 37.5% of the company. [403][404] However they are less effective against the South Africa variant, with Moderna reporting that the current vaccine produced only one-sixth of the antibodies in response to the South African variant compared with the original virus. Pajine in te ła categoria "Età moderna" Sta categoria ƚa ga drento ste 3 voxe, so 3 en tuto: D. Desfenestrasion de Praga; R. Rinasimento; T. Tratà de Tordesillas Ùltimo canbiamento de sta pàjina el 22 luj 2020 a ƚe 13:09. [34], In March 2020, in a White House meeting between the Trump administration and pharmaceutical executives, Bancel told the president that Moderna could have a COVID-19 vaccine ready in a few months. [50][51], Large pharmaceutical companies with experience in making vaccines at scale, including Johnson & Johnson, AstraZeneca, and GlaxoSmithKline (GSK), formed alliances with biotechnology companies, governments, and universities to accelerate progression to an effective vaccine. [419] Several companies plan to initially manufacture a vaccine at artificially low pricing, then increase prices for profitability later if annual vaccinations are needed and as countries build stock for future needs. [121], Scientists investigated whether existing vaccines for unrelated conditions could prime the immune system and lessen the severity of COVID‑19 infection. [24], In March 2013, Moderna and AstraZeneca signed a five-year exclusive option agreement to discover, develop, and commercialize mRNA for treatments in the therapeutic areas of cardiovascular, metabolic, and renal diseases, and selected targets for cancer. Storia moderna e contemporanea: Cronologia della storia moderna ... Muore Maria la sanguinaria e sale al trono Elisabetta I. Inizio dell'età elisabettiana. [98][99], Inactivated vaccines consist of virus particles that have been grown in culture and then are killed using a method such as heat or formaldehyde to lose disease producing capacity, while still stimulating an immune response. [10] The next day, the FDA approved clinical trials for the Moderna vaccine candidate, with Moderna later receiving investment of $483 million from Operation Warp Speed. For other Moderna vaccination topics, see. Il banditismo nell'età moderna va quindi considerato nel suo insieme come un fenomeno parapolitico che coinvolge vari strati sociali, con connessioni e complicità tra signori e banditi, investe indifferentemente zone urbane e rurali e presenta talora una forza tale da vincere quella dello stesso Stato incapace ancora di mediare tra le classi sociali. As of January 2021, authorized vaccines of this type are the Pfizer-BioNTech COVID‑19 vaccine[88][89][90] and the Moderna COVID-19 vaccine. [52][53], After a coronavirus was isolated in December 2019,[54] its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. National regulatory authorities have granted emergency use authorizations for nine vaccines. [427] While the purchasing contracts with vaccine manufacturers remain secret, they do not contain liability exemptions even for side-effects not known at the time of licensure. [189] In the case of COVID‑19, a vaccine efficacy of 67% may be enough to slow the pandemic, but this assumes that the vaccine confers sterilizing immunity, which is necessary to prevent transmission. Pace di Cateau-Cambrésis fra Asburgo e Francia. Durch das Weitersurfen auf etamoderna.de erklären Sie sich mit der Verwendung von Cookies einverstanden. [10], Moderna develops mRNAs that are delivered in lipid nanoparticle, using mRNA with pseudouridine nucleosides. [16] It was authorized for use in Canada on December 23, 2020,[17][18] as well as in the European Union on January 6, 2021. [11][10] Bancel has been described as having a secretive approach to Moderna, and as being a tough operator. [84][85][86][87], RNA vaccines were the first COVID-19 vaccines to be authorized in the United States and the European Union. Storia Moderna 1492 1848 Storia dell'Europa - Wikipedia Breve storia d’Italia dalle origini ai giorni nostri. Uno dei primi precursori delle organizzazioni umaniste contemporanee fu l'Associazione religiosa umanista fondata nel 1853 a Londra. Età moderna: dalla scoperta dell'America (1492) alla Rivoluzione francese (1789) e alla Rivoluzione industriale (1750) Età contemporanea: dalla Rivoluzione francese (1789) o dalla Rivoluzione industriale (1750) al presente. L'è caraterisàda da la nàssita stacc di modèrni in Euròpa e da la colonisassiù del mónd da part del Vècc Continènt. Vaccines against SARS[9] and MERS[10] have been tested in non-human animals. [431] [432] The vaccine was widely being used in the UAE, despite pending approval from the World Health Organization. ", "G20 launches initiative for health tools needed to combat the coronavirus", "Access to COVID-19 Tools (ACT) Accelerator", "The ACT-Accelerator: frequently asked questions (FAQ)", "Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine", "Canada to spend $192M on developing COVID-19 vaccine", "Government of Canada's research response to COVID-19", "US and China unleash wallets in race for coronavirus vaccine", "Government launches coronavirus vaccine taskforce as human clinical trials start", "In quest for vaccine, US makes 'big bet' on company with unproven technology", "U.S. 'Warp Speed' vaccine effort comes out of the shadows", "Trump introduces 'Warp Speed' leaders to hasten COVID-19 vaccine", "World Health Organization timeline – COVID-19", "Responding to Covid-19: A once-in-a-century pandemic? They're running an investment firm, and then hopefully it also develops a drug that's successful". [405], On 6 February 2021, The Financial Times reported that provisional trial data from a study undertaken by South Africa's University of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. [37][38], Since 2011, Moderna has been led by CEO Stéphane Bancel, a French businessman with a pharmaceutical sales and operations background. ; Politica de la ''privacy'' A propòsit de Wikipedia [55][64], On 24 June 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations. [32] Phase III trials typically involve more participants at multiple sites, include a control group, and test effectiveness of the vaccine to prevent the disease (an "interventional" or "pivotal" trial), while monitoring for adverse effects at the optimal dose. The delivery of mRNA is achieved by a coformulation of the molecule into lipid nanoparticles which protect the RNA strands and help their absorption into the cells. [389][390] As of 7 January, authorized and approved vaccines have shown efficacies ranging from 62–90% for the Oxford–AstraZeneca vaccine (various dosage regimens) to 95% for the Pfizer-BioNTech COVID‑19 vaccine. This mRNA then reprograms the cells to prompt immune responses. RNA vaccines often, but not always, use nucleoside-modified messenger RNA. [402], Early results suggest that both the Pfizer and Moderna vaccines protect against the UK variant. [1], As of February 2021[update], 66 vaccine candidates are in clinical research, including 17 in Phase I trials, 23 in Phase I–II trials, 6 in Phase II trials, and 20 in Phase III trials. Vai a: navigazione, ricerca. [19] Subsequently the mRNA-1273 was authorized in the United Kingdom on 8 January 2021. [397] The Novavax vaccine was found to be 89% effective in the UK. [44] China provided low-rate loans to a vaccine developer through its central bank and "quickly made land available for the company" to build production plants. All structured data from the file and property namespaces is available under the Creative Commons CC0 License; all unstructured text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. The WHO vaccine coalition will prioritize which vaccines should go into Phase II and III clinical trials, and determine harmonized Phase III protocols for all vaccines achieving the pivotal trial stage. La Età contemporanea è il periodo storico che inizia con la Rivoluzione industriale e giunge al presente. [406] The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal protection" in all but the most severe cases of COVID-19. Percentage of population that has received at least one dose of a COVID-19 vaccine. [437], In an effort to demonstrate the vaccine's safety, prominent politicians have received it on camera, with others pledging to do so. [93], As of January 2021, authorized vaccines of this type are the British Oxford–AstraZeneca COVID-19 vaccine,[94][95][96] Russian Sputnik V,[97] and Chinese Convidicea. Andrea Pisani was born in Venice in 1662, to a noble family belonging to the Venetian patriciate. [31][32] Definition of vaccine safety, efficacy, and clinical endpoints in a Phase III trial may vary between the trials of different companies, such as defining the degree of side effects, infection or amount of transmission, and whether the vaccine prevents moderate or severe COVID‑19 infection. Candidates are designed to have improved folding and translation efficiency via insertional mutagenesis. "Moderna vaccine" redirects here. It is one of the two RNA vaccines developed and deployed in 2020 against COVID-19, the other being the Pfizer–BioNTech vaccine. The study will utilize the shot developed by Pfizer and BioNTech with the University of Oxford and AstraZeneca shot, two vaccines which rely on different methods to deliver information to the cells of the recipient. It is an RNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Rossi had developed a method of modifying mRNA by first transfecting it into human cells, then dedifferentiating it into stem cells which could then be further redifferentiated into desired target cell types. ", "EMA sets 50% efficacy goal – with flexibility – for COVID vaccines", "Pfizer-BioNTech COVID-19 Vaccine – rna ingredient bnt-162b2 injection, suspension", "Information about the Pfizer-BioNTech COVID-19 Vaccine", Centers for Disease Control and Prevention, "China's Sinopharm says its coronavirus vaccine is 79% effective", "Brazil institute says CoronaVac efficacy above 50%, but delays full results", "Sinovac's Covid Shot Proves 78% Effective in Brazil Trial", "Moderna COVID-19 Vaccine – cx-024414 injection, suspension", "Novavax vaccine delivers 89% efficacy against COVID-19 in UK – but is less potent in South Africa", "Scientists Test a New Covid-19 Vaccine Question: Mixing Different Doses", "Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom", "South Africa coronavirus variant: What is the risk? ", "Alexion, Moderna announce agreement to develop messenger RNA therapeutics", "Why This Secretive Tech Start-Up Could Be The Next Theranos", "Moderna Had the Biggest Biotech IPO Ever. [409][410] Adjuvants used in COVID‑19 vaccine formulation may be particularly effective for technologies using the inactivated COVID‑19 virus and recombinant protein-based or vector-based vaccines. [429], On 18 January 2021, WHO Director-General Tedros Adhanom Ghebreyesus warned of problems with equitable distribution: "More than 39 million doses of vaccine have now been administered in at least 49 higher-income countries. A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus causing Coronavirus disease 2019 (COVID‑19). It encompassed every phase of development from research to manufacturing. licensed for prophylactic use against COVID-19, United States National Institute of Allergy and Infectious Diseases, Biomedical Advanced Research and Development Authority, "What we know about Moderna's COVID-19 vaccine candidate — and what we don't", "Moderna chairman: We don't need deep-freeze conditions for vaccine", "Moderna CEO Bancel joins Flagship Ventures as senior partner", "Christmas comes early as first Moderna vaccines arrive in Canada", "Moderna Reports Third Quarter 2020 Financial Results", "Moderna Makes Entrance with $40M Round for mRNA Work", "Moderna applies for FDA authorization for its Covid-19 vaccine", "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups", "Secretive Moderna yet to convince on $5bn valuation", "Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine", "COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval", "Canada could be among the first to clear Moderna's COVID-19 vaccine for use", "Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine", "Regulatory Decision Summary - Moderna COVID-19 Vaccine", "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)", "UPDATE 1-European Commission gives final approval to Moderna vaccine", "Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator", "ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells", "Moderna, $40M in Tow, Hopes to Reinvent Biotech with "Make Your Own Drug, "Can Moderna Live up to the Hype?